Search

everythinglearnresearchcommunity

for

Search:↓

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Psoriasis can cause temporary or permanent hair loss.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Optimized film improves finasteride skin absorption and treatment efficiency.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Some drugs used to treat inflammation may cause hair loss.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin conditions can signal heart issues, highlighting the need for integrated care.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.